Clinical focus and interest:
Dr. Patel focuses on developing biomarkers for personalized immunotherapy to better determine which combination of therapies works best for each individual. He is also interested in cancer immunotherapy and early-phase clinical trials involving immunotherapy across all types of cancer.
Dr. Patel completed a fellowship in medical oncology and hematology at the Duke University School of Medicine, Duke Medical Center, and a residency in internal medicine at the University of California, Los Angeles (UCLA) School of Medicine, UCLA Medical Center. He earned his medical degree at the Baylor College of Medicine and undertook research at the University of Texas MD Anderson Cancer Center during his studies. He is board certified in internal medicine, medical oncology, and hematology.
Dr. Patel is a leader for the Experimental Therapeutics (Phase I) Program and the co-leader of the NRG Developmental Therapeutics Committee. He also serves as the deputy director of the Center for Precision Immunotherapy at UCSD.